Irbesartan and Flector drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Irbesartan (irbesartan) and Flector (diclofenac epolamine). Common drug interactions include headache among females and peptic ulcer perforation among males.

The phase IV clinical study analyzes what interactions people have when they take Irbesartan and Flector. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

What is Flector?

Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.

On Jul, 20, 2026

29 people who take Irbesartan and Flector together, and have interactions are studied.

Irbesartan and Flector drug interactions.

What are the common drug interactions of Irbesartan and Flector, by gender? *:

female:

Headache (pain in head)
Asthenia (weakness)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Hyperkalaemia (damage to or disease of the kidney)
Pyrexia (fever)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Toxic skin eruption (skin breakdown due to toxic substance)
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Colitis (inflammation of colon)
Diarrhoea

male:

Peptic ulcer perforation
Acute respiratory failure
Renal failure acute (rapid kidney dysfunction)
Anaemia (lack of blood)
Chronic kidney disease
Muscle haemorrhage (bleeding in muscle)
Nephrogenic anaemia (anaemia due to kidney disease)
Phlebitis (inflammation of the walls of a vein)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Irbesartan and Flector, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

Asthenia (weakness)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Headache (pain in head)
Pyrexia (fever)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Toxic skin eruption (skin breakdown due to toxic substance)

60+:

Peptic ulcer perforation
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Depressed mood
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)
Headache (pain in head)
Heparin-induced thrombocytopenia
Jugular vein thrombosis (clot in jugular vein)
Muscle haemorrhage (bleeding in muscle)

What are the existing conditions these people have? *

Constipation: 13 people, 44.83%
Bronchial Carcinoma (lung cancer): 12 people, 41.38%
High Blood Cholesterol: 4 people, 13.79%
Type 2 Diabetes: 3 people, 10.34%
Joint Pain: 3 people, 10.34%
Antisynthetase Syndrome (chronic autoimmune disease of unknown cause): 3 people, 10.34%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.90%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 6.90%
Cardiac Disorder: 2 people, 6.90%
Back Pain: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and Flector?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously